Isolation from the horse genome of a new DNA transposon belonging to the Tigger family.
Paulis M
Mamm Genome. 15(5):399-403.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Broccoli A
Haematologica. 2017 Aug 3;102(11):1931-1935. doi: 10.3324/haematol.2017.171355
Infections after T-replete haploidentical transplantation and high-dose cyclophosphamide as graft-versus-host disease prophylaxis.
Crocchiolo R
Transpl Infect Dis. 17(2):242-9. doi: 10.1111/tid.12365
Induction of death receptor 5 expression in tumor vasculature by perifosine restores the vascular disruption activity of TRAIL-expressing CD34(+) cells.
Giacomini A
Angiogenesis. 2013 Apr 20;16(3):707-22. doi: 10.1007/s10456-013-9348-7
Improved clinical outcome in indolent B-cell lymphoma patients vaccinated with autologous tumor cells experiencing immunogenic death.
Zappasodi R
Cancer Res. 2010 Sep 30;70(22):9062-72. doi: 10.1158/0008-5472.CAN-10-1825
Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor.
Magni M
Leuk Res. 26(12):1131-3.
Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells.
Rizzo MT
Cancer Res. 59(19):5047-53.
In vitro growth of mobilized peripheral blood progenitor cells is significantly enhanced by stem cell factor.
Cesana C
Stem Cells. 15(3):207-13.
Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients.
Carlo-Stella C
Blood. 83(5):1373-80.
In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte–macrophage colony-stimulating factor.
Carlo-Stella C
Bone Marrow Transplant. 8(4):265-73.